Trexquant Investment’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
Other funds holding AERI
DM
PHS
GIM
LCS
Trexquant Investment's AERI Position: Q3 2021 in Review
Trexquant Investment sold out of Aerie Pharmaceuticals (AERI) in Q3 2021, closing a stake of 11,013 shares — an estimated $176K sold.
Trexquant Investment first reported a position in AERI in Q1 2015 and held it in 13 quarters. The position peaked at $1.6M in Q1 2018. 137 funds tracked by Wall St. Rank hold AERI as of Q3 2021.
- Trexquant Investment reported no remaining Aerie Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
- Trexquant Investment sold 11,013 Aerie Pharmaceuticals shares in Q3 2021, an estimated $176K.
- Trexquant Investment first reported a position in Aerie Pharmaceuticals in Q1 2015 and held it in 13 quarters.
- Trexquant Investment's Aerie Pharmaceuticals position peaked at $1.6M in Q1 2018.
- 137 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2021.
Based on Trexquant Investment's 13F filing for Q3 2021, filed 12 Nov 2021.